申请人:Fundación del Sector Público Estatal Centro
Nacional de Investigaciones Oncológicas Carlos III
(F.S.P. CNIO)
公开号:EP3623370A1
公开(公告)日:2020-03-18
Novel TRF1 modulators and analogues thereof.
There is provided compounds of Formula I, wherein R, R1, R2 and X have meanings written in the description. Such compounds are useful as TRF1 inhibitors and, for that reason, as medicaments, in the treatment of cancer, particularly high cancer stem cell cancer like glioblastoma and lung cancer, and can be also useful for the development of additional TRF1 inhibitors and increasing knowledge about TRF1 activity.
提供了Formula I的化合物,其中R、R1、R2和X的含义如描述中所述。这些化合物可用作TRF1抑制剂,因此可用作药物,用于治疗癌症,特别是高癌干细胞癌症,如胶质母细胞瘤和肺癌,并且还可用于开发额外的TRF1抑制剂,并增进对TRF1活性的了解。